Acute On Chronic Liver Failure Market

Acute-on-chronic liver failure is a syndrome that affects patients with chronic liver disease; is characterized by intense systemic inflammation, organ failure, and a poor prognosis; and frequently develops in close association with precipitating events. There is no specific treatment for patients with ACLF, and management is based on organ support, management of complications associated with specific etiologies, and liver transplantation.

Acute On Chronic Liver Failure Market contains market size and forecasts of Acute On Chronic Liver Failure in Global, including the following market information:

• Global Acute On Chronic Liver Failure Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Acute On Chronic Liver Failure market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acute On Chronic Liver Failure include Grifols Therapeutics, Promethera Biosciences, RHEACELL, Versantis AG and Martin pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Acute On Chronic Liver Failure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute On Chronic Liver Failure Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acute On Chronic Liver Failure Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Medication
• Others

Global Acute On Chronic Liver Failure Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acute On Chronic Liver Failure Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Acute On Chronic Liver Failure Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acute On Chronic Liver Failure Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Acute On Chronic Liver Failure revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Acute On Chronic Liver Failure revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Grifols Therapeutics
• Promethera Biosciences
• RHEACELL
• Versantis AG
• Martin pharmaceuticals